Alveo Technologies
Developer of a portable, point-of-need molecular diagnostic platform combining nucleic acid amplification with electrical impedance sensing, single-use cartridges, and a cloud-connected mobile workflow. The company offers assay co-development, cartridge transfer and production readiness support, and supports deployment for animal health, food safety, environmental surveillance and bioprocess monitoring.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Portable molecular analyzer (handheld)
Palm-sized analyzer for point-of-need nucleic acid amplification testing with rapid run times and design features for field ruggedness.
Single-use assay cartridges with barcode-based registration
Preloaded cartridges for single-use molecular assays with barcode identification to enable secure test registration and automated result traceability.
Mobile workflow and reporting application
Smartphone application that guides testing workflow, transmits encrypted results to the cloud, and supports role-based access and customizable reporting.
Sample filtration syringe
Handheld filtration device to prepare complex samples for more consistent molecular testing input.
Avian influenza assay panel
Assay panel configured to detect and differentiate avian influenza targets for on-site poultry surveillance.
Portable molecular analyzer (handheld)
Palm-sized analyzer for point-of-need nucleic acid amplification testing with rapid run times and design features for field ruggedness.
Single-use assay cartridges with barcode-based registration
Preloaded cartridges for single-use molecular assays with barcode identification to enable secure test registration and automated result traceability.
Mobile workflow and reporting application
Smartphone application that guides testing workflow, transmits encrypted results to the cloud, and supports role-based access and customizable reporting.
Sample filtration syringe
Handheld filtration device to prepare complex samples for more consistent molecular testing input.
Avian influenza assay panel
Assay panel configured to detect and differentiate avian influenza targets for on-site poultry surveillance.
Services
Collaborative program covering requirements definition, primer and assay optimization, cartridge conversion, verification and validation planning, and design transfer to production for cartridge-based molecular assays.
Collaborative program covering requirements definition, primer and assay optimization, cartridge conversion, verification and validation planning, and design transfer to production for cartridge-based molecular assays.
Expertise Areas
- Point-of-need molecular diagnostics
- NAAT assay development and primer optimization
- Assay cartridge design and traceability
- Device hardware design and ruggedization for field use
Key Technologies
- Nucleic acid amplification (including isothermal amplification)
- Electrical impedance-based detection
- Cartridge-based single-use assay systems
- Portable/handheld molecular analyzers
News & Updates
Partnership to deploy a point-of-care diagnostic across clinical sites in Nigeria and Sierra Leone.
Partnership announced for nationwide deployment of rapid, on-site avian influenza surveillance across Egypt.
First-phase evaluation demonstrating feasibility of the portable molecular testing platform for wastewater pathogen surveillance.
Grant awarded to support efforts to transform vaccine manufacturing speed and affordability.
Milestone agreement with CDC advanced development of rapid molecular testing capable of detecting and differentiating Influenza A, B and A(H5).
Published study results from a poultry medicine research center demonstrating sensitivity of the avian influenza assay.
Partnership to deploy a point-of-care diagnostic across clinical sites in Nigeria and Sierra Leone.
Partnership announced for nationwide deployment of rapid, on-site avian influenza surveillance across Egypt.
First-phase evaluation demonstrating feasibility of the portable molecular testing platform for wastewater pathogen surveillance.
Grant awarded to support efforts to transform vaccine manufacturing speed and affordability.
Milestone agreement with CDC advanced development of rapid molecular testing capable of detecting and differentiating Influenza A, B and A(H5).
Published study results from a poultry medicine research center demonstrating sensitivity of the avian influenza assay.